About Tom Gardner

Tom Gardner is founder of and senior advisor to Omeza Holdings, Inc. (skin regenerative medicine), co-founder of KeyView Labs with David Shrier (cognitive health supplements), former chairman of IntegriChain (sold to Accel-KKR), and former chairman of MMIT (sold to Welsh Carson). 

He is an advisor to Dandelion Science Corp. and the Visionary Future venture studio.  Tom is co-founder of LEAD for Life and BRIDGE Angel Investors and a director of The Save A Leg Save A Life Foundation (SALSAL), a 501(c)(3) charitable organization.

Prior to Omeza, Tom was CEO of several public and private companies including Nucryst Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to Procter & Gamble), Datamonitor (IPO on London Stock Exchange), Base Ten Systems (assets sold to Smiths Aerospace and ABB Group), and Access Health (sold to HBOC, now part of McKesson).  Earlier, Tom held marketing and general management positions at Procter & Gamble and Johnson & Johnson. 

He earned a B.A. in Economics and Mathematics from the University of St. Thomas (MN) and has been a guest lecturer on marketing channels at Northwestern University’s Kellogg Graduate School of Management.